Programme budgetting

•Download as PPT, PDF•

0 likes•387 views

The document discusses several proposed changes and improvements to health services in NHS Bedfordshire including: 1. Ring-fencing the dental budget until April 2011. 2. Decommissioning an underoccupied 8-bed learning disability inpatient unit. 3. Developing a business case to increase use of high street optometrists subject to training. 4. Creating an integrated community service for sexual health, pharmacy, and GP services. It emphasizes continual improvement, rethinking current provision, improving outcomes through better services or prevention, and achieving similar results for less cost through program budgeting.

Health & Medicine

Dental Budget: Ring-fenced till April 2011 Learning Disability: Standalone 8-bedded inpatient unit with low occupancy decommissioned Vision: Business case to increase use of High Street Optometrists subject to adequate training New Integrated Community Based Service for Sexual Health, Pharmacy and GP LES FOCUS ON CONTINUAL IMPROVEMENT MAJOR RETHINK OF CURRENT PROVISION IMPROVE SERVICE OR PREVENTION TO IMPROVE OUTCOMES ACHIEVE SIMILAR FOR LESS? Programme Budgets in NHS Bedfordshire Cancer : Strategic focus on patient experience and reducing inequality

What is the message? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

This slide has had a visual impact ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

How has this helped decision making? Examining the mental health programme budget ,[object Object],[object Object],[object Object]

How has this helped decision making? ,[object Object],[object Object],[object Object]

Contribution to Public Health Competencies ,[object Object],[object Object],[object Object],[object Object]

Appendix ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

What's hot

Local Care Organisations

Health and Care Innovation Expo

Implementing a Population Health Model (Timothy Ferris)

Ashleigh Kades

Planning by place: STPs

Health and Care Innovation Expo

Extended Primary Care Access in Southwark

Nuffield Trust

Just do it! - The sustainability of GS1 standards

GS1 UK

Community Health Worker Models: A focus on Sustainability HENRY PERRY

CORE Group

Pharmacy working together to put Lord Carter’s recommendations into practice

Health and Care Innovation Expo

Joint working between the NHS and pharmaPM Society

The Primary Care Home: A solutions focused new care model provider

Nuffield Trust

The vision for the Wessex AHSNPM Society

Leading for improvement: a framework for the NHS in England

Health and Care Innovation Expo

NHS partnership with Virginia Mason Institute - our journey so far

Health and Care Innovation Expo

Ann Coyle - Health Service ExecutiveCASALA CENTRE

New Models of General Practice: Practical and policy lessons

Nuffield Trust

Learning Disabilities: Share and Learn webinar - 26 May 2016

NHS England

Grand Round: RITHIM — A New Approach to Research in Manitoba

CHICommunications

Provision of dental services to care homessuchiey

Clinical and patient leadership

Health and Care Innovation Expo

Ashford and St. Peter's Hospitals NHS Foundation Trust- A culture based appro...

RuthEvansPEN

ABPI regional industry group - NICE to knowPM Society

What's hot (20)

Local Care Organisations

Implementing a Population Health Model (Timothy Ferris)

Planning by place: STPs

Extended Primary Care Access in Southwark

Just do it! - The sustainability of GS1 standards

Community Health Worker Models: A focus on Sustainability HENRY PERRY

Pharmacy working together to put Lord Carter’s recommendations into practice

Joint working between the NHS and pharma

The Primary Care Home: A solutions focused new care model provider

The vision for the Wessex AHSN

Leading for improvement: a framework for the NHS in England

NHS partnership with Virginia Mason Institute - our journey so far

Ann Coyle - Health Service Executive

New Models of General Practice: Practical and policy lessons

Learning Disabilities: Share and Learn webinar - 26 May 2016

Grand Round: RITHIM — A New Approach to Research in Manitoba

Provision of dental services to care homes

Clinical and patient leadership

Ashford and St. Peter's Hospitals NHS Foundation Trust- A culture based appro...

ABPI regional industry group - NICE to know

Viewers also liked

Recipe For Salmonella OutbreakInforming Healthier Choices Programme

DSD-INT 2014 - OpenMI Symposium - A selection of water-related applications o...

Deltares

South West Sustainability PosterInforming Healthier Choices Programme

Prevalent Pool Of DrinkersInforming Healthier Choices Programme

Commissioning support for LondonInforming Healthier Choices Programme

Working as a Government AnalystInforming Healthier Choices Programme

Quantifying Salmonella spp. in pig slaughterhouses and pork markets associate...

ILRI

Inequalities And Health In Hillingdon 2008Informing Healthier Choices Programme

Dr. Robert Tauxe - Antimicrobial Resistance and The Human-Animal Interface: T...

John Blue

Antimicrobial Resistance and The Human-Animal Interface: The Public Health Concerns - Dr. Robert Tauxe, Deputy Director, Division of Foodborne, Waterborne and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA. More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship

Viewers also liked (9)

Recipe For Salmonella Outbreak

DSD-INT 2014 - OpenMI Symposium - A selection of water-related applications o...

South West Sustainability Poster

Prevalent Pool Of Drinkers

Commissioning support for London

Working as a Government Analyst

Quantifying Salmonella spp. in pig slaughterhouses and pork markets associate...

Inequalities And Health In Hillingdon 2008

Dr. Robert Tauxe - Antimicrobial Resistance and The Human-Animal Interface: T...

Similar to Programme budgetting

150408 Posters for Evidence LiveAlison Turner

Sharing what works in the UK

Centre for Mental Health

Practical Guide to Benefits Driven Change

Minney org Ltd

Dr Hamzah BaigDoctors.net.uk

Program Evaluation

Winstina Kennedy

Organizational Capacity Assessments for Policy, Advocacy, Financing, and Gove...

MEASURE Evaluation

MSc Innovation

Matthew Armstead

Boutin essential benefitsAmerican Academy of Family Physicians

m&e-ppt-module-10.pptx

DR. MAQSOOD AHMAD

Joint Working workshopPM Society

Dh patient and public engagementhwbjyg

Build resources list v7

Courtney Bartlett

CBT nursing economic assessmentKaren Naya

How to Improve Healthcare Reporting Management System.pptx

Flutter Agency

NCCMT Spotlight Webinar: Guide to Policy-Influence Evaluation

The National Collaborating Centre for Methods and Tools

Interested in learning how to evaluate your policy influence? Do you promote the uptake and dissemination of population health interventions? Are you interested in exploring public health–related case studies of policy influence? The Guide to Policy-Influence Evaluation can help! This guide was developed by the Public Health Agency of Canada’s Innovation Strategy and produced by Cathexis Consulting. How can the Guide to Policy-Influence Evaluation help you? The Guide to Policy-Influence Evaluation was developed to help organizations use policy influence to improve the uptake and evaluation of evidence-based population health interventions. This process is divided into the four steps of evaluation planning. Each step includes two or more resources to support it. The resources are then summarized and important highlights are presented as they related to each step. This webinar includes an overview of the Guide by its developers, followed by a presentation from a community based organization who evaluated the impact on policies within their work to promote healthier weights. The Guide to Policy-Influence Evaluation includes three public health–related case studies: •Healthy weights among Aboriginal children and youth •Anti-bullying for primary schools •Food security and healthy weights To see the summary statement of this method developed by NCCMT, click here: http://www.nccmt.ca/resources/search/241 The National Collaborating Centre for Methods and Tools is funded by the Public Health Agency of Canada and affiliated with McMaster University. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada. NCCMT is one of six National Collaborating Centres (NCCs) for Public Health. The Centres promote and improve the use of scientific research and other knowledge to strengthen public health practices and policies in Canada.

Joan Saddler: Implications for putting patients and the public firstNuffield Trust

VBBD Webinar Dec 2010

archanasunil

VBBD Webinar Dec 2010

archanasunil

HIMSS ME Dubai Health Strategy 2016 - 2021Mazin Gadir PhD MSc BEng

Key Element 4 Increase Upstream InvestmentsA population health .docx

tawnyataylor528

Key Element 4: Increase Upstream Investments A population health approach maximizes its potential by directing efforts and investments “upstream” to address root causes of health and illness. What are upstream investments? Upstream investments are interventions aimed at the root causes of a population health problem or benefit. Root causes are often identified by determining the most immediate and direct causes, and working backwards from there. In many cases, upstream action addresses social, economic and environmental conditions. The population health approach is grounded in the notion that the earlier in the causal stream action is taken (i.e. the more upstream the action is), the greater the potential for population health gains and health-related cost savings. It is often true, however, that these root causes are more difficult to change, requiring more time, more resources and more will. Because of this, upstream interventions may not be the most appropriate choice; the context, timing, resources, mandate and available evidence must be considered. The choice should be based on the best evidence, not just on an article of faith that “further upstream is always better.” Resources to Increase Understanding: What are upstream investments? · The Case for Prevention: Moving Upstream to Improve Health of All Ontarians – Health Nexus (formerly the Ontario Prevention Clearinghouse) Key questions · a) What is the best balance of investments? · b) Who will provide support and what will it be? A) What is the best balance of investments? A population health approach recognizes the tension between short and long term goals. Health problems have to be treated immediately, but at the same time, upstream investments are needed to keep people healthy. Furthermore, upstream investments need sustained support to have a real impact. The population health approach strives to strike a balance between investments of three types: · Short term, e.g. responding to citizen concerns about the quality and accessibility of health care, food and drug safety, and emergency response procedures · Medium term, e.g. programs that favour equity, such as redistribution of resources, and programs that invest in children, such as responding to windows of developmental opportunity · Long term, e.g. investment in alternative energy sources and other technologies that reduce stress on the physical environment. B) Who will provide support and what will it be? Taking upstream action on the social, economic and environmental health determinants requires influencing how multiple sectors of government assign their resources. In this Key Element, it is important to identify what investments by what partners outside health are required. To generate this list, consider all the sectors whose mandates impact upon health determinants and focus on those that are most relevant. How are upstream investments increased? 4.1 Balance short, medium and long term investments The decision-making fram ...

Similar to Programme budgetting (20)

150408 Posters for Evidence Live

Sharing what works in the UK

Practical Guide to Benefits Driven Change

Dr Hamzah Baig

Program Evaluation

Organizational Capacity Assessments for Policy, Advocacy, Financing, and Gove...

MSc Innovation

Boutin essential benefits

m&e-ppt-module-10.pptx

Joint Working workshop

Dh patient and public engagement

Build resources list v7

CBT nursing economic assessment

How to Improve Healthcare Reporting Management System.pptx

NCCMT Spotlight Webinar: Guide to Policy-Influence Evaluation

Joan Saddler: Implications for putting patients and the public first

VBBD Webinar Dec 2010

HIMSS ME Dubai Health Strategy 2016 - 2021

Key Element 4 Increase Upstream InvestmentsA population health .docx

Recently uploaded

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Prix Galien International 2024 Forum Program

Levi Shapiro

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Anujkumaranit

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Catherine Liao

THOA 2.ppt Human Organ Transplantation Act

DrSathishMS1

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

KDIGO 2024 guidelines for diabetologists

د.محمود نجيب

Non-respiratory Functions of the Lungs.pdf

MedicoseAcademics

These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract. Learning objectives: 1. Enlist the non-respiratory functions of the respiratory tract 2. Briefly explain how these functions are carried out 3. Discuss the significance of dead space 4. Differentiate between minute ventilation and alveolar ventilation 5. Describe the cough and sneeze reflexes Study Resources: 1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition 3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition 4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874

Cervical & Brachial Plexus By Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya

Dr KHALID B.M

Couples presenting to the infertility clinic- Do they really have infertility...

Sujoy Dasgupta

Surgical Site Infections, pathophysiology, and prevention.pptx

jval Landero

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Krishan Murari

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

heat stroke and heat exhaustion in children

SumeraAhmad5

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya

Dr KHALID B.M

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Catherine Liao

Recently uploaded (20)

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx

Prix Galien International 2024 Forum Program

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

THOA 2.ppt Human Organ Transplantation Act

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

KDIGO 2024 guidelines for diabetologists

Non-respiratory Functions of the Lungs.pdf

Cervical & Brachial Plexus By Dr. RIG.pptx

Physiology of Chemical Sensation of smell.pdf

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya

Couples presenting to the infertility clinic- Do they really have infertility...

Surgical Site Infections, pathophysiology, and prevention.pptx

BRACHYTHERAPY OVERVIEW AND APPLICATORS

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

heat stroke and heat exhaustion in children

Evaluation of antidepressant activity of clitoris ternatea in animals

Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya

The hemodynamic and autonomic determinants of elevated blood pressure in obes...